Vitamin E in humans: Demand and delivery

被引:369
作者
Traber, MG [1 ]
Sies, H [1 ]
机构
[1] UNIV DUSSELDORF, INST PHYSIOL CHEM 1, D-40001 DUSSELDORF, GERMANY
关键词
tocopherol; lipoproteins; chylomicrons; VLDL; LDL; HDL; tocopherol transfer protein; ataxia with vitamin E deficiency;
D O I
10.1146/annurev.nu.16.070196.001541
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
How much vitamin E is enough? An established use of supplemental vitamin E in humans is in the prevention and therapy of deficiency symptoms. The cause of vitamin E deficiency, characterized by peripheral neuropathy and ataxia, is usually malabsorption-a result of fat malabsorption or genetic abnormalities in lipoprotein metabolism. Genetic abnormalities in the hepatic alpha-tocopherol transfer protein also cause vitamin E deficiency-defects in this protein cause an impairment in plasma vitamin E transport. Impaired delivery of vitamin E to tissues, thereby, results in deficiency symptoms. Also discussed is the use of supplemental vitamin E in chronic diseases such as ischemic heart disease, atherosclerosis, diabetes, cataracts, Parkinson's disease, Alzheimer's disease, and impared immune function, as well as in subjects receiving total parenterol nutrition. In healthy individuals, a daily intake of about 15-30 mg of alpha-tocopherol is recommended to obtain ''optimal plasma alpha-tocopherol concentrations'' (30 mu M or greater).
引用
收藏
页码:321 / 347
页数:27
相关论文
共 158 条
  • [11] BENNER SE, 1994, CANCER EPIDEM BIOMAR, V3, P73
  • [12] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS
    BERLINER, JA
    TERRITO, MC
    SEVANIAN, A
    RAMIN, S
    KIM, JA
    BAMSHAD, B
    ESTERSON, M
    FOGELMAN, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1260 - 1266
  • [13] BIESALSKI HK, 1995, DT ARZTEBL, V92, P1316
  • [14] REDUCED HEPATIC ALPHA-TOCOPHEROL CONTENT AFTER LONG-TERM ADMINISTRATION OF ETHANOL TO RATS
    BJORNEBOE, GEA
    BJORNEBOE, A
    HAGEN, BF
    MORLAND, J
    DREVON, CA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 918 (03) : 236 - 241
  • [15] BLANER WS, 1994, J BIOL CHEM, V269, P16559
  • [16] BLOMSTRAND R, 1968, INT Z VITAMINFORSCH, V38, P328
  • [17] NUTRITION INTERVENTION TRIALS IN LINXIAN, CHINA - SUPPLEMENTATION WITH SPECIFIC VITAMIN MINERAL COMBINATIONS, CANCER INCIDENCE, AND DISEASE-SPECIFIC MORTALITY IN THE GENERAL-POPULATION
    BLOT, WJ
    LI, JY
    TAYLOR, PR
    GUO, WD
    DAWSEY, S
    WANG, GQ
    YANG, CS
    ZHENG, SF
    GAIL, M
    LI, GY
    YU, Y
    LIU, BQ
    TANGREA, J
    SUN, YH
    LIU, FS
    FRAUMENI, JF
    ZHANG, YH
    LI, B
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18): : 1483 - 1492
  • [18] BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188
  • [19] BOSTICK RM, 1993, CANCER RES, V53, P4230
  • [20] VITAMIN-E IN HUMAN LOW-DENSITY-LIPOPROTEIN - WHEN AND HOW THIS ANTIOXIDANT BECOMES A PROOXIDANT
    BOWRY, VW
    INGOLD, KU
    STOCKER, R
    [J]. BIOCHEMICAL JOURNAL, 1992, 288 : 341 - 344